Skip to main navigation Skip to search Skip to main content

Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab

  • Katherine Van Loon
  • , Anne M. Espinoza
  • , David R. Fogelman
  • , Robert A. Wolff
  • , Milind M. Javle
  • , Renuka V. Iyer
  • , Vincent J. Picozzi
  • , Ludmila Katherine Martin
  • , Tanios Bekaii-Saab
  • , Margaret A. Tempero
  • , Nathan R. Foster
  • , George P. Kim
  • , Andrew H. Ko

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science